1910
A Senior Computational/Theoretical Chemist at 1910 leads computational chemistry programs that support AI-enabled drug discovery across therapeutic modalities. The role focuses on applying quantum chemistry and molecular simulation methods to inform hit-to-lead and lead optimization and to integrate computational insights with experimental workflows. The position works closely with AI/ML engineers, medicinal chemists, and biologists to translate simulations and models into experimentally testable candidates.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2018
1910 is an AI-native biotech company building multimodal, modality-agnostic AI infrastructure for pharmaceutical R&D. Its ITO™ platform integrates wet‑lab, computational, and proxy data to power predictive models and end‑to‑end workflows that help companies discover and reliably "drug the undruggable." 1910’s technology is designed to accelerate target selection, molecule design, and experimental decision‑making, reducing time and cost in the drug discovery pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1910.
1910 didn’t post a salary, so this is our estimate from similar listings.
Bucoda incorporates on July 5, 1910.
Sep 2, 2025